These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37482056)

  • 1. Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center.
    Bonn J; Baltin CT; Osterkamp V; Scheid C; Holtick U; Irsch J; Kron F
    Oncol Res Treat; 2023; 46(9):362-369. PubMed ID: 37482056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implementation of a patient data management system. Effects on intensive care documentation].
    Castellanos I; Ganslandt T; Prokosch HU; Schüttler J; Bürkle T
    Anaesthesist; 2013 Nov; 62(11):887-90, 892-7. PubMed ID: 24126951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conventional vs pathogen-inactivated platelet concentrates for the treatment of perioperative coagulopathy. A prospective cohort study].
    Weber CF; Meininger D; Byhahn C; Seifried E; Zacharowski K; Adam E; Henschler R; Müller MM
    Chirurg; 2011 Apr; 82(4):348-58. PubMed ID: 21249326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model calculations to quantify clinical and economic effects of pathogen inactivation in platelet concentrates.
    Berger K; Bauer M; Schopohl D; Henschler R; Ostermann H
    Onkologie; 2013; 36(1-2):53-9. PubMed ID: 23429333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective DRG coding : Improvement in cost-effectiveness and documentation quality of in-patient hospital care].
    Geuss S; Jungmeister A; Baumgart A; Seelos R; Ockert S
    Chirurg; 2018 Feb; 89(2):138-145. PubMed ID: 29188352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland.
    Jutzi M; Mansouri Taleghani B; Rueesch M; Amsler L; Buser A
    Transfus Med Hemother; 2018 May; 45(3):151-156. PubMed ID: 29928168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre.
    Amato M; Schennach H; Astl M; Chen CY; Lin JS; Benjamin RJ; Nussbaumer W
    Vox Sang; 2017 Jan; 112(1):47-55. PubMed ID: 28001297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.
    Wilke MH; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Dec; 16(12):543-8. PubMed ID: 22112361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost recovery for the treatment of retinal and vitreal diseases by pars plana vitrectomy under the German DRG system].
    Framme C; Franz D; Mrosek S; Helbig H
    Ophthalmologe; 2007 Oct; 104(10):866-74. PubMed ID: 17882428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost calculations for treating penetrating eye injuries within the DRG C01Z at a university eye hospital].
    Framme C; Franz D; Mrosek S; Helbig H; Sachs HG
    Ophthalmologe; 2008 Oct; 105(10):936-42. PubMed ID: 18351359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of hand surgery in the German and Italian DRG systems].
    Lotter O; Dolderer J; Stahl S; Atzei A; Haerle M; Schaller HE
    Gesundheitswesen; 2011 Dec; 73(12):843-8. PubMed ID: 20886418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of flat-rate payment in radiation oncology. German experience with disease-related groups for inpatient funding in radiation oncology].
    Glocker S; Loskamp N; Bamberg M; Roeder N
    Strahlenther Onkol; 2006 Jun; 182(6):305-11. PubMed ID: 16703284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health economic evaluation of an internal medicine intermediate care unit (IMC) with gastroenterological focus at a maximum care university hospital - Evaluating the Profitability of Intermediate Care (IMC) in modern University Hospital Gastroenterology].
    Katsounas A; Lütkes P; Canbay A; Gerken G
    Z Gastroenterol; 2023 Jan; 61(1):37-49. PubMed ID: 36623542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the 90-day cost structure of lower extremity revascularization for alternative payment model assessment.
    Duwayri YM; Aiello FA; Tracci MC; Nedza S; Ryan PC; Adams JG; Shutze WP; Lum YW; Woo K
    J Vasc Surg; 2021 Feb; 73(2):662-673.e3. PubMed ID: 32652115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inpatient treatment costs, cost-driving factors and potential reimbursement problems due to epileptic seizure-related injuries and fractures].
    Verboket RD; Mühlenfeld N; Sterz J; Störmann P; Marzi I; Balcik Y; Rosenow F; Strzelczyk A; Willems LM
    Chirurg; 2021 Apr; 92(4):361-368. PubMed ID: 32757045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin - A real-world data and retrospective cost analysis.
    Baltin CT; Wulf C; Rongisch R; Lehmann C; Wingen-Heimann S; Eisenmenger N; Bonn J; Fabri M; von Stebut E; Cornely OA; Kron F
    J Infect Public Health; 2023 Jun; 16(6):955-963. PubMed ID: 37099955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DRG reimbursement for multiple trauma patients -- a comparison with the comprehensive hospital costs using the German trauma registry].
    Grotz M; Schwermann T; Lefering R; Ruchholtz S; Graf v d Schulenburg JM; Krettek C; Pape HC
    Unfallchirurg; 2004 Jan; 107(1):68-75. PubMed ID: 14749855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total inpatient treatment costs in patients with severe burns: towards a more accurate reimbursement model.
    Mehra T; Koljonen V; Seifert B; Volbracht J; Giovanoli P; Plock J; Moos RM
    Swiss Med Wkly; 2015; 145():w14217. PubMed ID: 26599581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Academic health systems management: the rationale behind capitated contracts.
    Taheri PA; Butz DA; Greenfield LJ
    Ann Surg; 2000 Jun; 231(6):849-59. PubMed ID: 10816628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.